Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Entera Bio Ltd
(NQ:
ENTX
)
1.670
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Entera Bio Ltd
< Previous
1
2
3
Next >
$5.1 Million Bet On Tabula Rasa HealthCare? 3 Penny Stocks Insiders Are Buying
July 26, 2022
US crude oil futures traded higher by around 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
July 22, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Via
Benzinga
Entera Bio Outlines Pivotal Osteoporosis Trial, Names New CEO
July 18, 2022
Via
Benzinga
Recap: Entera Bio Q1 Earnings
May 12, 2022
Entera Bio (NASDAQ:ENTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: Entera Bio Q4 Earnings
March 08, 2022
Entera Bio (NASDAQ:ENTX) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
82 Biggest Movers From Yesterday
June 15, 2022
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.
Via
Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
June 14, 2022
Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy.
Via
Benzinga
Follow the Insiders and Buy the Dip in These 3 Stocks
May 06, 2022
These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.
Via
InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
4 Penny Stocks Insiders Are Buying: Crexendo, Performant Financial And More
January 20, 2022
Silver prices surged above $24 per troy ounce for the first time in more than two months and investors also focused on some notable insider...
Via
Benzinga
5 Penny Stocks Insiders Are Buying
January 19, 2022
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
October 06, 2021
Entera Bio Ltd (NASDAQ: ENTX) has presented the 6-month bone mineral density (BMD) data from its Phase 2 trial of EB613, an oral formulation of human parathyroid...
Via
Benzinga
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ...
Via
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
45 Biggest Movers From Yesterday
June 24, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...
Via
Benzinga
Earnings Scheduled For August 16, 2021
August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to...
Via
Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Where Might Entera Bio Stock End Up After Rallying Wednesday
June 23, 2021
Entera Bio Ltd (NASDAQ: ENTX) shares rallied higher Wednesday after the company announced it saw positive results from its final six-month bone mineral density results from...
Via
Benzinga
ENTX Stock: The Huge FDA News Sending Entera Bio Soaring
June 23, 2021
Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials.
Via
InvestorPlace
Exposures
Product Safety
Mid-Afternoon Market Update: Patterson Companies Drops On Earnings Miss; Entera Bio Shares Gain
June 23, 2021
Toward the end of trading Wednesday, the Dow traded down 0.08% to 33,918.98 while the NASDAQ rose 0.16% to 14,276.41. The S&P also rose, gaining 0.05% to 4,248.47. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Notches Intraday High, SPX Eyes Third-Straight Win
June 23, 2021
The Dow Jones Industrial Average is modestly lower this afternoon, walking back this morning's gains to register a 19-point drop.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
June 23, 2021
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) are among the biggest biopharma movers Wednesday. Entera Bio Climbs...
Via
Benzinga
Why Entera Bio Shares Are Skyrocketing Today
June 23, 2021
Entera Bio Ltd (NASDAQ: ENTX) shares are trading higher by 47.66% at $6.63 Wednesday after the company announced the topline Phase 2 clinical trial of EB613 met its primary...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises Over 1%; Gemini Therapeutics Shares Slide
June 23, 2021
Midway through trading Wednesday, the Dow traded up 0.01% to 33,948.64 while the NASDAQ rose 0.19% to 14,280.41. The S&P also rose, gaining 0.10% to 4,250.86. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
31 Stocks Moving In Wednesday's Mid-Day Session
June 23, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)...
Via
Benzinga
Mid-Morning Market Update: Markets Rise; IHS Markit Earnings Beat Views
June 23, 2021
Following the market opening Wednesday, the Dow traded up 0.14% to 33,991.54 while the NASDAQ rose 0.38% to 14,307.88. The S&P also rose, gaining 0.19% to 4,254.30. The U.S....
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
32 Stocks Moving In Friday's Mid-Day Session
June 18, 2021
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,...
Via
Benzinga
58 Biggest Movers From Friday
June 21, 2021
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.